Melatonin has a wide range of benefits in people with cancer. It is an immune booster (increases NK cells that fight cancer), inhibits angiogenesis, increases apoptosis, alleviates many of the side effects of chemotherapy and radiation thereapy, and is safe, affordable, and available.
Research from Cancer Treatment Centers of America shows that melatonin in a dosage from 10-40 mg per day increased the one year survival of state 4 cancers by 45%. The five year survival rate for stage four cancers using conventional therapies in the US is about 2%.
Melatonin has many other metabolic effects. To learn more about this click here.